Copyright © 2005, European Society of Cardiology
Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences
Section of Cardiology, Department of Medicine, The Division of Biological Sciences and Pritzker School of Medicine, The University of Chicago, 5841 S Maryland Ave, MC6088, Chicago, IL, 60637, United States
* Tel.: +1 773 834 0705; fax: +1 773 702 2681. Email address: lcai{at}medicine.bsd.uchicago.edu hcai{at}medicine.bsd.uchicago.edu
Received 22 February 2005; revised 16 June 2005; accepted 17 June 2005
| Abstract |
|---|
|
|
|---|
Increased production of reactive oxygen species (ROS) has been implicated in the pathogenesis of cardiovascular diseases. Enzymatic systems such as the mitochondrial respiratory chain, vascular NAD(P)H oxidases, xanthine oxidase, and uncoupled endothelial nitric oxide synthase (eNOS) produce superoxide anion (O2.–) in vascular cells. While some O2.– rapidly degrades by reacting with nitric oxide (NO.), the O2.– signal preserved by dismutation into hydrogen peroxide (H2O2) exerts prolonged signaling effects. This review focuses on patterns and mechanisms whereby H2O2 modulates different aspects of endothelial cell function including endothelial cell growth and proliferation, endothelial apoptosis, endothelium-dependent vasorelaxation, endothelial cytoskeletal reorganization and barrier dysfunction, endothelial inflammatory responses, and endothelium-regulated vascular remodeling. These modulations of endothelial cell function may at least partially underlie H2O2 contribution to the development of vascular disease.
KEYWORDS Hydrogen peroxide; Endothelial function; Superoxide; Nitric oxide; Growth; Actin cytoskeleton; Barrier function; Inflammation; Vascular remodeling; Vascular NAD(P)H oxidases; Uncoupled endothelial nitric oxide synthase; Xanthine oxidase; Mitochondrion; Nox
Increased production of reactive oxygen species (ROS) has been implicated in the pathogenesis of cardiovascular diseases such as atherosclerosis, restenosis, hypertension, diabetic vascular complications and heart failure [1–7]. One electron reduction of molecular oxygen forms superoxide anion (O2.–), which serves as a progenitor for hydrogen peroxide (H2O2). By rapidly inactivating nitric oxide (NO.), O2.– contributes to endothelial dysfunction [7]. H2O2 however modulates endothelial cell function via intricate mechanisms. Ambient production of O2.– and subsequently H2O2 at low levels, maintained by basal activity of pre-assembled endothelial NAD(P)H oxidases [3], or potential leakage from mitochondrial respiration [8], is necessary for endothelial cell growth and proliferation. Under pathological conditions, agonists-provoked activation of vascular NAD(P)H oxidases and subsequently activated xanthine oxidase or uncoupled eNOS produce H2O2 in large quantities [9–11], leading to detrimental consequences [12,13]. These dual-faced functions of H2O2 are similar to what is characteristic of NO.: vasodilating and protective at physiological concentrations but microbicidal and apoptotic when produced in large quantities. The current review discusses enzymes responsible for endothelial production of ROS, patterns and mechanisms whereby H2O2 influences different aspects of endothelial cell function and H2O2 contribution to vascular disease development.
| 1. Production and metabolism of hydrogen peroxide |
|---|
|
|
|---|
In mammalian cells, potential enzymatic sources of ROS include the mitochondrial electron transport chain, the arachidonic acid metabolizing enzymes lipoxygenase and cycloxygenase, the cytochrome P450s, xanthine oxidase, NAD(P)H oxidases, uncoupled nitric oxide synthase (NOS), peroxidases, and other hemoproteins. These systems primarily catalyze one electron reduction of molecular oxygen to form O2.– which rapidly inactivates NO. to form peroxynitrite. Under ambient conditions, some O2.– is dismutated to H2O2 spontaneously or catalyzed by superoxide dismutase (SOD). Of interest, loss of NO. could lead to enhanced formation of H2O2. Some enzymes, such as xanthine oxidase and glucose oxidase, can directly produce H2O2 by donating two electrons to oxygen. In the presence of heavy metals, H2O2 undergoes Fenton reaction to form highly reactive hydroxyl radical (HO.). When bound to peroxidases such as catalase, H2O2 forms compound I which oxidizes NO. to nitrogen dioxide anion (NO2–) and react with NO2– to form nitrogen dioxide radical (NO2.). NO2. in turn participates in nitrating events such as formation of nitrotyrosines [14,15]. Fig. 1 illustrates biochemical pathways of H2O2 generation and metabolism. When produced transiently at high concentrations, H2O2 and HO. are capable of directly oxidizing proteins and lipids, and causing DNA strand breaks. At relatively lower pathophysiological concentrations (nano- to micromolar range) however, H2O2 plays important signaling roles in endothelial cells, and these are the focus of the current review.
|
| 2. Vascular NAD(P)H oxidases |
|---|
|
|
|---|
Accumulating evidence has characterized a predominant role of vascular NAD(P)H oxidases in generating ROS in different vascular cells including endothelial cells, vascular smooth muscle and fibroblasts [1–6]. In endothelial cells, though there is much to be learned, it is clear that p47phox modulates enzymatic activity by interacting with membrane and cytosolic components to form the active complex. The gp91phox [also called Nox2, Nox for NAD(P)H oxidases, representing a family of novel NAD(P)H oxidases] is the catalytic core of this complex [16–19]. Studies using deficient mice or inhibitory peptide targeting Nox2 have established an essential role of Nox2 in producing ROS in endothelial cells [17,18,20,21]. Functions of the newly cloned gp91phox homologues; Nox1, Nox4 and Nox5 however, remain obscure. Nox4 seems to express more abundantly in endothelial cells compared to other Nox proteins, representing the major catalytic unit of the endothelial NAD(P)H oxidase responsive to growth halting [22,23]. Nox1 on the other hand, was upregulated by oscillatory shear stress, mediating ROS-dependent leukocyte adhesion to endothelium [24]. Furthermore, VEGF receptor-dependent activation of Nox1 induced angiogenic tube formation of endothelial cells [25]. The observations that Nox1 mediates growth signaling while Nox4 is growth suppressive in endothelial cells seems similar to what have been observed in vascular smooth muscle [26,27]. It seems odd that the same ROS-producing Nox proteins mediate different cellular responses. It is possible that the function of each Nox protein is dependent on its distinctive subcellular localization, and is subject to specific regulations by selective agonists [4]. For example, in vascular smooth muscle cells, Nox1 localizes to caveolae while Nox4 is found in focal adhesions [28]. In endothelial cells however, Nox4 was found at endoplasmic reticulum [23] whereas Nox2 is localized to peri-nuclear cytoskeletal structure [17].
Novel homologues of Nox-regulating proteins p47phox and gp67phox have been identified in epithelial cells (p41phox and p51phox respectively), serving as potent positive regulators for Nox1 [29–32]. In the same cells longer Nox proteins with peroxidase tails, namely Duox1 and Duox2, have been cloned [33,34] and shown to be functional [35,36]. These proteins are yet studied for their presence and function in endothelium and vascular smooth muscle. Of note, p22phox is the only other membrane component of the vascular NAD(P)H oxidases. Overexpression of p22phox led to stabilization of Nox1 and Nox4 proteins [37]. Recent studies have elegantly characterized physical and functional interactions between p22phox and Noxs (Nox1 and Nox4) in vascular smooth muscle [38,39]. Similar interactions might also occur in endothelial cells. In addition, a recent study reported that p22phox expression correlates well with expression of Nox4 in human arteries and that of Nox2 in veins [40].
In addition, vascular NAD(P)H oxidase-derived H2O2 is able to amplify ROS production in vascular cells. To date at least five different mechanisms are involved in this propagation, including enhanced intracellular iron uptake, and activation of sources of mitochondria, NAD(P)H oxidases, xanthine oxidase and uncoupled eNOS [1]. These feed-forward mechanisms form a vicious circle to amplify and sustain H2O2 production in large quantities, contributing to prolonged pathological signaling.
| 3. Hydrogen peroxide regulation of endothelial cell growth and proliferation |
|---|
|
|
|---|
H2O2 generated by xanthine oxidase or glucose oxidase stimulated endothelial cell growth [41]. Consistently, scavenging H2O2 by adenoviral overexpression of catalase or cytosolic glutathione peroxidase inhibited endothelial cell proliferation [42,43]. These data indicate a role of H2O2 in growth signaling. Indeed, H2O2 is downstream of Flk1/KDR, proceeding activation of ERK1/2 [44]. The growth regulating p90RSK, an important downstream effector of ERK1/2, is activated by H2O2 in endothelial cells [45]. Furthermore, H2O2 feed-forwardly increases endothelial VEGF expression and secretion via activation of PKC and NF
B [46], and regulates expression and function of other growth factors [47]. Growth signaling induced by agonists other than growth factors may also require H2O2. For instance, cyclic strain induces early growth factor 1 (Egr-1) expression and this requires H2O2-dependent activation of ERK1/2 [48]. Furthermore, H2O2 increases activity of eIF4E, an eukaryotic initiation factor of protein synthesis [49], and is effective in promoting endothelial cell tube formation [50,51]. Hypoxia induced activation of ERK1/2 and p38 MAPK in lung endothelial cells is mediated by H2O2 [52]. This may partially underlie hypoxia-induced angiogenesis. Indeed, endogenously produced H2O2 upregulates VEGF expression and angiogenesis in vivo [53]. The signaling events involved in H2O2 modulation of endothelial cell growth, and later discussed endothelial apoptosis are illustrated in Fig. 2. Whereas a modest increase in endothelial cell growth and angiogenesis is beneficial in repairing ischemic damage [54], excessive growth contributes to atheroma formation post injury [53]. In addition, when H2O2 diffuses to adjacent vascular smooth muscle, it could induce hypertrophy [13]. Indeed, endogenously overproduced H2O2 augmented angiotensin II induced vascular hypertrophy [55].
|
| 4. Hydrogen peroxide regulation of endothelial apoptosis |
|---|
|
|
|---|
Cultured umbilical vein endothelial cells are particularly prone to oxidative damage and often used to study H2O2 induced apoptosis. Of note, aortic endothelial cells undergo no significant cell death with exogenous addition of H2O2 less than 200 µmol/L [56–58]. However, 50–100 µmol/L H2O2 was apoptotic for umbilical vein endothelial cells. Endogenous H2O2, stimulated by oxidized LDL, induced endothelial cell apoptosis via JNK activation [59]. Mitochondrion-dependent ROS propagation is likely involved because mitochondria-targeted antioxidant abrogated H2O2 activation of JNK and apoptosis [60]. Studies by other groups also support a role for JNK/c-Jun in H2O2 induced apoptosis of endothelial cells [59,61,62]. Of note, Chen et al. previously characterized upstream events of JNK activation by H2O2, which involve Src-dependent activation of EGFR [63]. Additionally, H2O2 upregulates Fas expression [64], enhances intracellular ion uptake [65], and induces mitochondrial DNA damage [66], all of which may directly trigger apoptosis.
Importantly, endothelial cell apoptosis has been implicated in atherosclerosis [67,68] although molecular mechanisms underlying H2O2 induced endothelial cell apoptosis remain to be fully elucidated. It is however interesting to note that H2O2 induced apoptosis is inhibitable by unidirectional laminar shear stress, which exerts this effect by attenuating JNK activation and enhancing glutathione reductase-dependent glutathione redox-cycling [69,70]. Furthermore, S-nitrosylation of thioredoxin 1 [71] and ERK5 activation [72] was found protective of endothelial cells from apoptosis.
| 5. Hydrogen peroxide regulation of endothelial barrier function and actin cytoskeleton |
|---|
|
|
|---|
Relatively high concentrations of H2O2 (>200 µmol/L) increase endothelial permeability [73], and this seems mediated by activations of PKC [74], phosphodiesterase [75], small G protein Rho [76], Src tyrosine kinase [77], p38 MAPK [78], and an increase in intracellular calcium [79]. Tight junction protein occludin was found downstream of ERK1/2 in mediating H2O2-induced barrier dysfunction [80]. In addition, H2O2 downregulation of intracellular cAMP content appears important in inducing barrier dysfunction [75,81]. Decreased PKA activity can itself account for many of the activating effects that result in barrier dysfunction or at least permit those changes [82]. Crosstalks or spatial regulations among above-described signaling events however remain to be revealed. Caveolin-1 is expressed abundantly in lipid rafts of endothelial cell membrane, where it plays an important role in modulating barrier function [83]. Whether caveolin-1 is required for H2O2 modulation of endothelial barrier function however is unclear although our unpublished data suggest that H2O2 induces rapid Src-dependent phosphorylation of caveolin-1. Of note, at various concentrations, NO. is able to enhance or offset H2O2-induced loss of endothelial barrier function [84,85].
It has been shown that cytoskeletal reorganization modulates vascular permeability [86]. Likewise, H2O2 regulation of barrier function is linked to its effects on endothelial actin cytoskeleton. p38 MAPK phosphorylation of actin binding protein HSP27 mediates reorganization of actin cytoskeleton in H2O2-stimulated endothelial cells [87]. In keeping with this, H2O2 induced formation of actin stress fibers was found to be mediated by CaMKII-dependent activation of p38 MAPK/HSP27 and ERK1/2 [88]. Whereas HSP27 phosphorylation was completely prevented by blockade of p38 MAPK, inhibition of ERK1/2 only transiently attenuated HSP27 phosphorylation [88]. These data suggest that ERK1/2 has different downstream effectors in modulating actin cytoskeleton.
It was previously shown that endothelial MLCK is involved in H2O2 induced actin reorganization [89]. MLCK also plays an important role in thrombin induced endothelial barrier dysfunction [86]. Thrombin has been shown to stimulate endothelial NAD(P)H oxidase activation and subsequent H2O2 production [90]. Recent studies further demonstrated that thrombin upregulates p22phox expression via p38 MAPK and PI-3K/AKT [91]. Given these observations, it is interesting to speculate that MLCK lies downstream of ERK1/2 in mediating H2O2 induced actin reorganization. In addition, H2O2 phosphorylation of tropomyosin-1 is ERK1/2-dependent, preceding its co-localization with developing actin filaments [92]. Of note, H2O2 activation of phospholipase D is also involved in actin reorganization in endothelial cells [93], likely serving as upstream activator of ERK1/2 [94]. The signaling events described above are summarized as part of the Fig. 3. Importantly, H2O2 regulation of endothelial cytoskeleton and barrier function may not only mediate ischemia–reperfusion induced acute vascular injury [73], but also potentiate vascular inflammation to contribute to chronic vascular disease [95].
|
| 6. Hydrogen peroxide regulation of endothelium-dependent vasorelaxation and eNOS expression |
|---|
|
|
|---|
Earlier studies demonstrated that H2O2 produces endothelium-dependent and independent vasorelaxation [96,97]. The endothelium-dependent vasorelaxation caused by H2O2 in large vessels depends on eNOS, as L-NAME (NOS inhibitor) abolishes it [98,99]. Indeed, H2O2 can acutely stimulate eNOS production of NO. via PI3-K/AKT and ERK1/2, [58,100]. When eNOS was uncoupled to produce O2.– rather than NO. in hypertensive or atherosclerotic large vessels, endothelium-derived H2O2 mediated compensatory relaxation via unknown mechanisms [10,101]. One possibility is direct polarization of vascular smooth muscle.
Indeed, H2O2 was found to be an endothelium-derived hyperpolarizing factor in small arteries [102,103] and an activator of potassium channel in large cerebral arteries [104]. In human coronary arterioles, flow-induced vasodilatation is mediated by endothelium-derived H2O2 [105]. In these arterioles, the enzymatic source of H2O2 appears to be the mitochondrial respiratory chain whereas in large vessels, vascular NAD(P)H oxidases are responsible for H2O2 production [6,8]. This seems consistent with previous observations that NO. plays a lesser role in vasodilatation of small arteries. Of note, in coronary arterioles, H2O2 induced endothelium-dependent vasorelaxation is NO.-independent involving activation of cyclooxygenase 1 and smooth muscle potassium channel [106]. Therefore, it is clear that H2O2 is capable of mediating endothelium-dependent vasorelaxation, NO.-dependently or independently. The underlying mechanisms however are diverse depending on the size of the blood vessels and the availability of functional eNOS to produce NO. [107,108].
H2O2 can also stimulate endothelium-independent vasorelaxation with unknown mechanisms [109–111]. Early studies demonstrated that H2O2 can directly activate cyclic GMP via a compound I/H2O2 complex [109,110]. Additional recent studies suggest that this might be true [112]. Known and hypothetical mechanisms underlying H2O2 induced vasorelaxation are summarized schematically in Fig. 4.
|
Of note, H2O2 potently upregulates eNOS expression in vitro and in vivo [37,56,113]. Oscillatory shear stress upregulation of eNOS requires H2O2 activation of CaMKII [114]. These observations are consistent with previous findings that eNOS is upregulated in animal models of atherosclerosis, diabetes or aging, where vascular H2O2 production is increased [115,116]. Rapidly accumulating evidence suggests that eNOS can become uncoupled to produce O2.– under conditions such as hypertension and atherosclerosis, likely consequent to tetrahydrobiopterin deficiency and oxidation. Thus upregulation of eNOS could be less beneficial or even detrimental while functioning as an oxidase. Indeed, our recent study indicates that endothelial NAD(P)H oxidase-derived H2O2 downregulates tetrahydrobiopterin salvage enzyme dihydrofolate reductase (DHFR) and DHFR/eNOS ratio in response to angiotensin II, leading to tetrahydrobiopterin deficiency and subsequently uncoupling of eNOS [9].
| 7. Hydrogen peroxide regulation of endothelial inflammatory responses |
|---|
|
|
|---|
Exposure of endothelial cells to H2O2 (50–100 µmol/L) increased surface expression of intercellular adhesion molecule-1 (ICAM-1) [117]. Furthermore, endogenously produced H2O2 mediates ischemia–reperfusion induced upregulation of ICAM-1 [118] and MCP-1 (monocyte chemoattractant protein-1) [119]. H2O2 is also required for TNF
induction of ICAM-1 and VCAM-1 (vascular cell adhesion molecule-1) [120], and upregulation of MCP-1 by TNF
[121] or hyperglycemia [122]. Additionally, activation of NF
B by H2O2 was found responsible for TNF
induction of ICAM-1 [123] and angiotensin II upregulation of VCAM-1 [124]. Endothelial expression of platelet activating factor (PAF) [125] and P-selectin [126] is inducible by H2O2. All these molecules including ICAM-1, VCAM-1, MCP-1, PAF and P-selectin have been shown to mediate neutrophil adhesion to endothelium (Fig. 5). PAF and P-selectin also mediates platelet activation and endothelium–platelet interaction. Upregulation of Mac 1 (CD11b and CD18) in neutrophils [127] by H2O2 stimulates more H2O2 release from activated neutrophils [128], forming a vicious circle. Taken together, these data strongly suggest that H2O2 mediates endothelial expression of inflammatory proteins and enhanced platelet–endothelium interaction, which in turn contributes to development of atherosclerotic vascular disease. The events described above are summarized in Fig. 5.
|
| 8. Hydrogen peroxide regulation of endothelium-mediated vascular remodeling |
|---|
|
|
|---|
Emerging evidence seems to suggest that H2O2 plays an important role in mediating vascular remodeling. First of all, H2O2 increases endothelial MMP-2 expression [12]. TGF-β1 and macrophages are important regulators of tissue fibrosis and remodeling. TGF-β1 induction of macrophage colony-stimulating factor, and IL-1 induction of plasminogen activator inhibitor-1 (PAI-1) in endothelial cells were found dependent on H2O2 activation of NF
B [129,130]. PAI-1 plays an important role in vascular remodeling induced by thrombosis [131] or chronic eNOS inhibition [132]. Recent studies demonstrated that PAI-1 is also critically important for angiotensin II or salt-induced vascular remodeling in vivo [133]. Thus by mediating TGF-β1 and PAI-1 signaling and MMP release, H2O2 contributes to endothelium-regulated vascular remodeling, which has been shown to regulate stability of atherosclerotic plaques [134]. | 9. Contribution of hydrogen peroxide to vascular disease |
|---|
|
|
|---|
To date, the specific, individual ROS that is most relevant to vascular signaling pathophysiologically is yet identified. Nevertheless, selectively overproducing or removing H2O2 significantly altered atherogenesis in animal models. Mice overexpressing p22phox had markedly increased atheroma formation in a carotid ligation model [53]. This response was associated with enhanced H2O2 production in the vessel wall, and was abolished by scavenging H2O2 with ebselen, implicating a critical role of H2O2 [53]. Parallel studies from another group confirmed the same notion [135]. Yang et al. cross bred transgenic mice overexpressing Cu/Zn-SOD or catalase, with mice deficient in apolipoprotein E (apoE–/–), to examine a specific role of H2O2 versus O2.– in atherogenesis [135]. They found that whereas overexpressing Cu/Zn-SOD had no effect on atherosclerotic lesion formation, overexpression of catalase, or co-overexpression of catalase and Cu/Zn-SOD markedly retarded atherosclerosis in all aspects [135]. These observations were consistent with the findings by Tribble et al. that overexpression of Cu/Zn-SOD failed to prevent atherosclerosis in high fat diet-fed apoE–/– mice [136]. Taken together, these data suggest that H2O2 is more atherogenic than O2.–. It is true that Cu/Zn-SOD is intracellular and overexpression of Cu/Zn-SOD can not protect NO. during its trafficking to vascular smooth muscle. Thus extracellular SOD might be more important in determining NO. bioavailability and be more anti-atherosclerosis. Indeed, evidence gained from ecSOD-null mice and adenovirus-mediated overexpression of ecSOD supports that ecSOD is the main determinant of NO. bioavailability in the vessel wall, and is thus involved in blood pressure regulation [137,138]. However, impact of ecSOD overexpression on atherosclerosis is yet to be reported although mice deficient in ecSOD developed similar atherosclerotic lesions compared to wild-type mice [139]. Therefore, whereas O2.– is important in directly modulating NO. bioavailability and serving as the precursor for H2O2 [7], relatively lasting H2O2 seems more important in mediating atherogenic signaling.
In summary, O2.– and H2O2 are produced in vascular cells by multiple enzymatic systems including vascular NAD(P)H oxidases, mitochondrion, xanthine oxidase and uncoupled eNOS. While some O2.– spontaneously degrades by reacting with NO., O2.– signal preserved by dismutation into H2O2 exerts prolonged signaling effects. This may explain why direct scavenging H2O2 but not O2.– is more effective in athero-protection. Although there is much to be learned, the impact of H2O2 on different aspects of endothelial cell function as discussed throughout the review may at least partially underlie H2O2-mediated development of atherosclerotic vascular disease.
| Acknowledgements |
|---|
The author's work is supported by an American Heart Association Scientist Development Grant (#0435189N), an American Diabetes Association Research Award, a Career Development Award from the Schweppe Foundation, and a Start-up Fund from the University of Chicago.
| Notes |
|---|
Time for primary review 27 days
| References |
|---|
|
|
|---|
- Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res (2005) 96:818–822.
[Abstract/Free Full Text] - Brandes R.P., Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res (2005) 65:16–27.
[Abstract/Free Full Text] - Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol (2004) 287:R1014–R1030.
[Abstract/Free Full Text] - Griendling K.K. Novel NAD(P)H oxidases in the cardiovascular system. Heart (2004) 90:491–493.
[Free Full Text] - Touyz R.M., Schiffrin E.L. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol (2004) 122:339–352.[CrossRef][ISI][Medline]
- Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci (2003) 24:471–478.[CrossRef][Medline]
- Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res (2000) 87:840–844.
[Abstract/Free Full Text] - Liu Y., Zhao H., Li H., Kalyanaraman B., Nicolosi A.C., Gutterman D.D. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res (2003) 93:573–580.
[Abstract/Free Full Text] - Chalupsky K., Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of eNOS. Proc Natl Acad Sci U S A (2005) 102:9056–9061.
[Abstract/Free Full Text] - Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 111:1201–1209.[CrossRef][ISI][Medline]
- McNally J.S., Davis M.E., Giddens D.P., Saha A., Hwang J., Dikalov S., et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol (2003) 285:H2290–H2297.
[Abstract/Free Full Text] - Belkhiri A., Richards C., Whaley M., McQueen S.A., Orr F.W. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. Lab Invest (1997) 77:533–539.[ISI][Medline]
- Zafari A.M., Ushio-Fukai M., Akers M., Yin Q., Shah A., Harrison D.G., et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension (1998) 32:488–495.
[Abstract/Free Full Text] - Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem (2002) 277:17415–17427.
[Abstract/Free Full Text] - Baldus S., Eiserich J.P., Brennan M.L., Jackson R.M., Alexander C.B., Freeman B.A. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med (2002) 33:1010.[CrossRef][ISI][Medline]
- Bayraktutan U., Blayney L., Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol (2000) 20:1903–1911.
[Abstract/Free Full Text] - Li J.M., Shah A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem (2002) 277:19952–19960.
[Abstract/Free Full Text] - Frey R.S., Rahman A., Kefer J.C., Minshall R.D., Malik A.B. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res (2002) 90:1012–1019.
[Abstract/Free Full Text] - Li J.M., Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II: role of the p47phox subunit. J Biol Chem (2003) 278:12094–12100.
[Abstract/Free Full Text] - Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res (2000) 87:26–32.
[Abstract/Free Full Text] - Furst R., Brueckl C., Kuebler W.M., Zahler S., Krotz F., Gorlach A., et al. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res (2005) 96:43–53.
[Abstract/Free Full Text] - Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation (2004) 109:227–233.
[Abstract/Free Full Text] - Buul J.D., Fernandez-Borja M., Anthony E.C., Hordijk P.L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal (2005) 7:308–317.[CrossRef][ISI][Medline]
- Sorescu G.P., Song H., Tressel S.L., Hwang J., Dikalov S., Smith D.A., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res (2004) 95:773–779.
[Abstract/Free Full Text] - Kobayashi S., Nojima Y., Shibuya M., Maru Y. Nox1 regulates apoptosis and potentially stimulates branching morphogenesis in sinusoidal endothelial cells. Exp Cell Res (2004) 300:455–462.[CrossRef][ISI][Medline]
- Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res (2001) 88:888–894.
[Abstract/Free Full Text] - Geiszt M., Kopp J.B., Varnai P., Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A (2000) 97:8010–8014.
[Abstract/Free Full Text] - Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 24:677–683.
[Abstract/Free Full Text] - Geiszt M., Lekstrom K., Witta J., Leto T.L. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem (2003) 278:20006–20012.
[Abstract/Free Full Text] - Banfi B., Clark R.A., Steger K., Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem (2003) 278:3510–3513.
[Abstract/Free Full Text] - Takeya R., Ueno N., Kami K., Taura M., Kohjima M., Izaki T., et al. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem (2003) 278:25234–25246.
[Abstract/Free Full Text] - Kawahara T., Kuwano Y., Teshima-Kondo S., Takeya R., Sumimoto H., Kishi K., et al. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol (2004) 172:3051–3058.
[Abstract/Free Full Text] - Edens W.A., Sharling L., Cheng G., Shapira R., Kinkade J.M., Lee T., et al. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol (2001) 154:879–891.
[Abstract/Free Full Text] - Lambeth J.D. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol (2002) 9:11–17.[CrossRef][ISI][Medline]
- Geiszt M., Witta J., Baffi J., Lekstrom K., Leto T.L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J (2003) 17:1502–1504.
[Abstract/Free Full Text] - Forteza R., Salathe M., Miot F., Conner G.E. Regulated H2O2 production by Duox in human airway epithelial cells. Am J Respir Cell Mol Biol (2005) 32:462–469.
[Abstract/Free Full Text] - Laude K., Cai H., Fink B., Hoch N., Weber D.S., McCann L., et al. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol (2005) 288:H7–H12.
[Abstract/Free Full Text] - Hanna I.R., Hilenski L.L., Dikalova A., Taniyama Y., Dikalov S., Lyle A., et al. Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med (2004) 37:1542–1549.[CrossRef][ISI][Medline]
- Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem (2004) 279:45935–45941.
[Abstract/Free Full Text] - Guzik T.J., Sadowski J., Kapelak B., Jopek A., Rudzinski P., Pillai R., et al. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol (2004) 24:1614–1620.
[Abstract/Free Full Text] - Ruiz-Gines J.A., Lopez-Ongil S., Gonzalez-Rubio M., Gonzalez-Santiago L., Rodriguez-Puyol M., Rodriguez-Puyol D. Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol (2000) 35:109–113.[CrossRef][ISI][Medline]
- Zanetti M., Katusic Z.S., O'Brien T. Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation. Am J Physiol Heart Circ Physiol (2002) 283:H2620–H2626.
[Abstract/Free Full Text] - Faucher K., Rabinovitch-Chable H., Barriere G., Cook-Moreau J., Rigaud M. Overexpression of cytosolic glutathione peroxidase (GPX1) delays endothelial cell growth and increases resistance to toxic challenges. Biochimie (2003) 85:611–617.[Medline]
- Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem (2002) 277:3101–3108.
[Abstract/Free Full Text] - Abe J., Okuda M., Huang Q., Yoshizumi M., Berk B.C. Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras. J Biol Chem (2000) 275:1739–1748.
[Abstract/Free Full Text] - Chua C.C., Hamdy R.C., Chua B.H. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med (1998) 25:891–897.[CrossRef][ISI][Medline]
- Eyries M., Collins T., Khachigian L.M. Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium (2004) 11:133–139.[CrossRef][ISI][Medline]
- Wung B.S., Cheng J.J., Chao Y.J., Hsieh H.J., Wang D.L. Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells. Circ Res (1999) 84:804–812.
[Abstract/Free Full Text] - Duncan R.F., Peterson H., Hagedorn C.H., Sevanian A. Oxidative stress increases eukaryotic initiation factor 4E phosphorylation in vascular cells. Biochem J (2003) 369:213–225.[CrossRef][ISI][Medline]
- Shono T., Ono M., Izumi H., Jimi S.I., Matsushima K., Okamoto T., et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 16:4231–4239.[Abstract]
- Yasuda M., Ohzeki Y., Shimizu S., Naito S., Ohtsuru A., Yamamoto T., et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci (1999) 64:249–258.[CrossRef][ISI][Medline]
- Parinandi N.L., Kleinberg M.A., Usatyuk P.V., Cummings R.J., Pennathur A., Cardounel A.J., et al. Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 284:L26–L38.
[Abstract/Free Full Text] - Khatri J.J., Johnson C., Magid R., Lessner S.M., Laude K.M., Dikalov S.I., et al. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation (2004) 109:520–525.
[Abstract/Free Full Text] - Sellke F.W., Simons M. Angiogenesis in cardiovascular disease: current status and therapeutic potential. Drugs (1999) 58:391–396.[CrossRef][ISI][Medline]
- Weber D.S., Rocic P., Mellis A.M., Laude K., Lyle A.N., Harrison D.G., et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2005) 288:H37–H42.
[Abstract/Free Full Text] - Cai H., Davis M.E., Drummond G.R., Harrison D.G. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol (2001) 21:1571–1576.
[Abstract/Free Full Text] - Cai H., Li Z., Dikalov S., Holland S.M., Hwang J., Jo H., et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem (2002) 277:48311–48317.
[Abstract/Free Full Text] - Thomas S.R., Chen K., Keaney J.F. Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem (2002) 277:6017–6024.
[Abstract/Free Full Text] - Lin S.J., Shyue S.K., Liu P.L., Chen Y.H., Ku H.H., Chen J.W., et al. Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. J Mol Cell Cardiol (2004) 36:129–139.[CrossRef][ISI][Medline]
- Chen K., Thomas S.R., Albano A., Murphy M.P., Keaney J.F. Jr. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J Biol Chem (2004) 279:35079–35086.
[Abstract/Free Full Text] - Wang N., Verna L., Hardy S., Zhu Y., Ma K.S., Birrer M.J., et al. c-Jun triggers apoptosis in human vascular endothelial cells. Circ Res (1999) 85:387–393.
[Abstract/Free Full Text] - Ramachandran A., Moellering D., Go Y.M., Shiva S., Levonen A.L., Jo H., et al. Activation of c-Jun N-terminal kinase and apoptosis in endothelial cells mediated by endogenous generation of hydrogen peroxide. Biol Chem (2002) 383:693–701.[CrossRef][ISI][Medline]
- Chen K., Vita J.A., Berk B.C., Keaney J.F. Jr. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem (2001) 276:16045–16050.
[Abstract/Free Full Text] - Suhara T., Fukuo K., Sugimoto T., Morimoto S., Nakahashi T., Hata S., et al. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol (1998) 160:4042–4047.
[Abstract/Free Full Text] - Kotamraju S., Tampo Y., Keszler A., Chitambar C.R., Joseph J., Haas A.L., et al. Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: role of ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (2003) 100:10653–10658.
[Abstract/Free Full Text] - Ballinger S.W., Patterson C., Yan C.N., Doan R., Burow D.L., Young C.G., et al. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res (2000) 86:960–966.
[Abstract/Free Full Text] - Dimmeler S., Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med (2004) 82:671–677.[CrossRef][ISI][Medline]
- Stoneman V.E., Bennett M.R. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) (2004) 107:343–354.[Medline]
- Hermann C., Zeiher A.M., Dimmeler S. Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol (1997) 17:3588–3592.
[Abstract/Free Full Text] - Hojo Y., Saito Y., Tanimoto T., Hoefen R.J., Baines C.P., Yamamoto K., et al. Fluid shear stress attenuates hydrogen peroxide-induced c-Jun NH2-terminal kinase activation via a glutathione reductase-mediated mechanism. Circ Res (2002) 91:712–718.
[Abstract/Free Full Text] - Haendeler J., Hoffmann J., Tischler V., Berk B.C., Zeiher A.M., Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol (2002) 4:743–749.[CrossRef][ISI][Medline]
- Pi X., Yan C., Berk B.C. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res (2004) 94:362–369.
[Abstract/Free Full Text] - Lum H., Barr D.A., Shaffer J.R., Gordon R.J., Ezrin A.M., Malik A.B. Reoxygenation of endothelial cells increases permeability by oxidant-dependent mechanisms. Circ Res (1992) 70:991–998.
[Abstract/Free Full Text] - Siflinger-Birnboim A., Goligorsky M.S., Del Vecchio P.J., Malik A.B. Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability. Lab Invest (1992) 67:24–30.[ISI][Medline]
- Suttorp N., Weber U., Welsch T., Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest (1993) 91:1421–1428.[ISI][Medline]
- Hippenstiel S., Tannert-Otto S., Vollrath N., Krull M., Just I., Aktories K., et al. Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am J Physiol (1997) 272:L38–L43.[ISI][Medline]
- Kevil C.G., Okayama N., Alexander J.S. H(2)O(2)-mediated permeability II: importance of tyrosine phosphatase and kinase activity. Am J Physiol Cell Physiol (2001) 281:C1940–C1947.
[Abstract/Free Full Text] - Usatyuk P.V., Vepa S., Watkins T., He D., Parinandi N.L., Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal (2003) 5:723–730.[CrossRef][ISI][Medline]
- Siflinger-Birnboim A., Lum H., Del Vecchio P.J., Malik A.B. Involvement of Ca2+ in the H2O2-induced increase in endothelial permeability. Am J Physiol (1996) 270:L973–L978.[ISI][Medline]
- Kevil C.G., Oshima T., Alexander B., Coe L.L., Alexander J.S. H(2)O(2)-mediated permeability: role of MAPK and occludin. Am J Physiol Cell Physiol (2000) 279:C21–C30.
[Abstract/Free Full Text] - Hastie L.E., Patton W.F., Hechtman H.B., Shepro D. H2O2-induced filamin redistribution in endothelial cells is modulated by the cyclic AMP-dependent protein kinase pathway. J Cell Physiol (1997) 172:373–381.[CrossRef][ISI][Medline]
- Patterson C.E., Lum H. Update on pulmonary edema: the role and regulation of endothelial barrier function. Endothelium (2001) 8:75–105.




